AGM, page-97

Well I disagree with both those statements.

Firstly, mentioning something at an AGM presentation is hardly Chinese whispers. This typical of your use of highly emotive language to try and strengthen a weak rhetorical position.

Secondly we have already been told that Coldry sales revenue from the BM facility will help defray necessary R&D costs for that plant and the sales would not necessarily be profitable if they were viewed against the plant running costs exclusive of the R&D requirement. I thank Ash (or Glenn) for providing a verbal indication of the quantum so that everyone can keep this in perspective.

The Revenue/Profit thing was due to Spider (I think) misspeaking and has already been queried and corrected. Why bring it up again other than to try and throw some more kero on the flames? Again, a typical rhetorical flourish when you feel you are losing the argument.

No need to worry about my business thanks mate, but I am concerned if you think A$1M of annual cost recovery trumps what was discussed at the AGM which, if the Arrowhead report is to be believed, amounts to EBITDA of about A$40M per year once the cookie cutters are all commissioned and running smoothly. Again, a skewed rhetorical position, offered, I suspect, with mischief in mind.